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 Background. The mental health stigma of pharmacists, the most accessible health 
professional, can have a significant impact on not only how these patient’s seek 
treatment, but also their quality of life (Mey et al., 2013). This study intends to explore 
mental health stigma among pharmacists and also examine the need for continuing 
education focused on mental health. 
 Methods. This study was a descriptive cross-sectional study that employed a self-
administered online survey. The subjects were pharmacist members of the Mississippi 
Pharmacists Association (MPhA). Demographic characteristics were collected. The level 
of mental health stigma among the respondents was examined using the Community 
Attitudes Toward the Mentally Ill (CAMI) scale in its full 40-question format. Social 
desirability bias that was evaluated using a validated 13 question revision of the Marlow-
Crowne Social Desirability scale. The final variable measured was the interest in mental-
health specific continuing education. Descriptive statistics were employed to meet study 
objectives.  
 Results. Caucasian females practicing in Mississippi composed the majority of 
respondents with an average age of 51 and an average of 26 years of practice. Most 
respondents considered their geographic location to be urban and their primary practice 
setting as an independent community pharmacy at which they were employed full-time. 
In relation to their personal experience with mental illness, the majority reported having 
at the least observed someone they believed had a mental illness in passing or on 
 v 
television. The results of the CAMI scale indicated that, on average, the pharmacists 
disagreed with the concepts of the authoritarianism and social restrictiveness subscales 
and agreed with those of the benevolence subscale. The average for the CMHI subscale 
was approximately in the mid-range and did not indicate agreement or disagreement. 
Respondents indicated a variety of continuing education needs related to mental illness. 
 Conclusion. Pharmacists generally indicated low levels of stigma with regard to 
mental illness, however, they indicate a need for continuing education in a variety of 
treatment areas. Continuing education providers are encouraged to provide programming 
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Mental Illness and Its Presence in Society 
 According to the National Alliance on Mental Illness (NAMI), one in every 5 US 
adults lived with a mental illness in 2018. 1 in every 25 of these adults suffered 
specifically from a severe mental illness (“Mental Illness,” 2019). Mental illness can be 
generally defined as a health condition that directly affects one’s emotions, mental 
processes or behavior and can greatly affect one’s functioning in every aspect of life 
(“Mental Health Conditions”). In the United States today, half of adults will experience 
some form of mental illness at any given point in their life (Kapil, 2019). With 
adolescents, ages 13 to 18, having the highest prevalence at a staggering 49.5% and a 
quarter of young adults aged 18 to 25 living with a mental illness, the increasing number 
of diagnoses could foreshadow a much larger presence of mental illness in the everyday 
lives of citizens in years to come (“Mental Illness,” 2019). Currently, 1 in every 8 visits 
to the emergency room is due to some form of mental illness or substance abuse (“Mental 
Health by…,” 2019). Not only does mental illness cause an increase of almost a billion 
dollars globally per year for hospitals due to relapses, the impact can be felt across all 
sectors of the economy (Rüsch et al., 2005). The estimated economic cost of mental 
illness within the next 20 years is projected to be at least $16 trillion dollars and expected 
to be more. In the United States alone, $100-$170 billion dollars will be lost in annual 
income to those struggling with mental illnesses (“Mental Health by…,” 2019). Mental 
illness has also been ranked among the top 10 most costly illnesses to U.S. employers due 
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to employee absences and lower productivity (Davlasheridze et al., 2018). With numbers 
drastically increasing, mental illness could potentially become a much larger concern as 
younger generations reach adulthood. 
 Despite the growing numbers of individuals diagnosed with mental illness 
annually, there is a deficit of mental health services available in the United States. 
According to NAMI, nationally only 43% of adults living with a mental illness within the 
United States received treatment in 2018. The average delay between the first 
developments of a mental health condition and receiving treatment is 11 years and many 
times patients either do not continue treatment or don’t adhere correctly to their 
respective therapies (“Mental Health by…,” 2019).  
  Although quite a few medications are available and behavioral therapies have 
been developed, there are multiple reasons as to why patients may not receive treatment 
for mental health conditions. Firstly, the cost of receiving mental health treatment has 
caused a huge barrier for multiple reasons. In 2018, massive budget cuts were made 
related to the treatment of mental health disorders including a $400 million-dollar budget 
cut for mental health and substance abuse programs and $6.2 billion dollars in funding to 
housing programs (Sperling, 2017). Additionally, many insurance companies have 
reduced spending on mental health services, forcing patients to pay millions of dollars in 
out-of-pocket costs (Winerman, 2017) A gap in the availability of health care 
professionals has caused more expenses for patients as well, forcing patients to drive long 
distances just to receive treatment (Wood et al., 2018). Due to the shortage of resources, 
many of those who are in desperate need of treatment have to turn to services that are not 
fit to give them the resources they need. Despite these efforts to change the focus of the 
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Department of Mental Health to more widespread community-based facilities rather than 
state mental hospitals, there was a $14 million cut to the budget of the Department of 
Mental Health just a year later (Smith, 2017). Another major barrier to patients seeking 
treatment is the existence of mental health stigma. 
 Beginning in approximately 700-480 B.C., the idea of stigma was presented as a 
method of labeling criminals and slaves. Those with mental illnesses were often included 
in this label and suffered years of torture being categorized as criminals. Entering the 
Middle Ages, this stigma translated into the assumption that developing such illnesses 
was somehow a punishment from God and meant one was evil or possessed, leading to 
more murder and torture until the Enlightenment period (Cressman, 2014). 
  Although there was less of a presence for a short period of time, mental health 
stigma again came to light in the 1940s with the introduction of sterilization. (Rossler, 
2016). In modern-day culture, the concept of mental illness and what the term entails is 
greatly influenced by media outlets. In Kalpana Srivastava’s article “Media and Mental 
Illness,” he states that “mass media not only reflect public attitudes and values but also 
take a part in shaping them.” With the dramatized, flawed and exploited representation of 
mental illness in the media shaping the public’s definition, many view individuals with 
such illnesses in a derogatory way. Such social isolation and exclusion have led to an 
increased stigma toward those living with mental illnesses. Use of stereotypes, prejudice, 
and discrimination to create an “us” compared to “them” narrative has gradually led to 
the idea of “self-stigma” that has caused a large portion of patients to either decline 
treatment or stop it early on to avoid the discrimination associated with it (Rüsch et al., 
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2005).  Mental health stigma can be seen everywhere, but one concerning aspect of 
mental health stigma is its existence among healthcare professionals. 
Mental Health Stigma Among Healthcare Professionals 
 The World Health Organization (WHO) defines health professionals as those 
who, “… play a central and critical role in improving access and quality health care for 
the population. They provide essential services that promote health, prevent diseases and 
deliver health care services to individuals, families and communities based on the 
primary health care approach.”  Frequent interactions with those with mental illnesses 
allow health professionals to be a major resource for help and treatment, but stigma has 
been reported to have a negative effect on the potential of this treatment. 
Mental health stigma among healthcare professionals can be defined as a negative 
demeanor toward patients due to bias or prejudice and is in response to apparent signs of 
a mental illness based on a personal or stereotypical viewpoint (Black et al., 2009). The 
presence of this stigma is speculated to be due to a “culture” within the healthcare 
community that influences the perception of those with mental illnesses and their 
importance compared to those with other forms of illnesses (Knaak et al., 2017).  
 Patients have reported feeling ignored and treated as though they are less-than-
human by their healthcare professionals. Due to this expectation, many are hesitant to 
seek treatment. When they do, many times it is of lesser quality due to the strained 
relationship between provider and patient and can also present some safety concerns 
(Knaak et al., 2017). Research shows the effects of stigma on the availability and quality 
of treatment towards those with mental illnesses along with many reporting that it has an 
impact on self-esteem and social interactions in both personal and business affairs as well 
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(D’Arrigo, 2017). Stigma also is correlated with a lack of personnel trained and pursuing 
work in the field (Alfredsson et al., 2017). Among those professionals that do pursue a 
career related to mental health, many report a feeling of under-preparedness and stress 
that ultimately leads to a level of uneasiness when approached by a patient with a mental 
illness (Knaak et al., 2017). Within every team of healthcare professionals involved in the 
treatment plan for each patient, the pharmacists play an important role in influencing the 
outcome of each treatment plan and the level of comfort the patient experiences.  
Mental Health Stigma Among Pharmacists 
 Pharmacists are the most available mental health professionals and also the 
professional that patients see most frequently (Mey et al., 2013). The Journal of 
American Pharmacists Association presented multiple studies showing that mental health 
stigma among pharmacists has contributed to a negative impact on patients’ self-image 
and social interactions (D’Arrigo, 2017). This stigma can lead to pharmacists being 
discriminatory and affect the quality of care for those with mental illnesses in the 
pharmacy setting (Giannetti et al., 2018).  
 The development of mental health stigma could be attributed to a number of 
influences including inexperience in the field, lack of exposure and knowledge, and a 
personal bias toward individuals with mental illnesses. These influences effect how 
pharmacists interact in the workplace with those with mental illnesses (Alfredsson et al., 
2017, Giannetti et al., 2018). Those with no experience in mental health actually express 
the most stigma according to a study conducted by Vincent Gianetti (Giannetti et al., 
2018). The drastic impact that stigma has had on the well-being of those with mental 
illnesses can easily be seen in the extent of stigma along pharmacists alone. Negative 
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attitudes toward individuals with mental illnesses among pharmacists can be correlated 
with less effective, lower quality treatment and a greater number of relapses (Alfredsson 
et al., 2017). Pharmacists have the potential to be a very important presence within the 
mental health community with the ability to influence the adherence and attitudes of 
patients toward medication treatment (Bell et al., 2006)(Murphy et al., 2016). With half 
of the patients on antipsychotic medications failing to fully adhere to the presented plan 
of treatment, pharmacists could play a large role in encouraging patients by developing 
ways to help patients feel more comfortable and confident with their understanding and 
motivation to adhere to medication regimens (Rüsch et al., 2005). Additional studies 
show that some mental health patients report being comfortable but felt as though there is 
a lack of medication monitoring and consideration (Caley & Stimmel, 2012). 
 Dr. Emily Black, in her article titled “Community Pharmacist Services for People 
with Mental Illnesses: Preferences, Satisfaction, and Stigma,” presents the idea that 
patients reporting feeling comfortable may be unaware of services that could be provided 
but are not due to the presence of mental health stigma (Black et al., 2009).  With future 
generations presenting growing numbers of patients presenting with signs of mental 
illness, decreasing this stigma among pharmacists could be a large step toward providing 
higher quality health care services and increasing adherence to medication therapy in the 
future. 
 Along with improving the services currently offered, pharmacists have the 
potential to offer additional services to patients with mental illnesses. They could have 
the opportunity to work alongside other providers in contributing their knowledge of side 
effects, drug interactions, dosage and cost information when creating medication therapy 
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ffor patients (Kinast et al., 2015). Also, pharmacists may play a role in offering additional 
services, such as depression screenings, and referring patients toward resources and 
services of other professionals (Gammage & Emberley, 2015). 
Mental Health Stigma Among Pharmacists – Literature Review 
 As mentioned previously, mental health stigma among pharmacists can lead to 
poorer quality of care for individuals living with mental illness and may be a contributing 
factor to why patients do not receive adequate treatment. Although multiple studies show 
that pharmacists seem to express positive attitudes, they do report being uncomfortable in 
a close and more intimate setting such as counseling (Watkins et al., 2017). Pharmacists 
report other factors contributing to their inability to provide adequate treatment including 
time restraints and a lack of privacy. Another major contributor to pharmacists’ hesitation 
in approaching the treatment of patients with mental illness is a lack of knowledge.  
 Overall, pharmacists report a lack of knowledge of mental health not only in the 
United States but in other countries including the United Kingdom (Murphy et al., 2014). 
Some studies, in contrast, show that pharmacists do feel as though their education was 
sufficient, but their level of comfort with counseling and discussing symptoms with those 
patients was not (Goodman et al., 2017). Some articles presented the idea of mental 
health literacy being an avenue of decreasing mental health stigma among pharmacists by 
increasing the level of knowledge and confidence speaking with patients regarding 
mental illness.  
Mental health literacy can be defined as “the knowledge and beliefs about mental 
disorders which aid in their recognition, management and prevention” (Oreilly et al., 
2010). One study expressed that pharmacists who scored higher in their level of mental 
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health literacy were more to conduct medication counseling or offer care. (Oreilly et al., 
2015). With the main concern reported being communication skills, many scientists 
began to conduct studies and research different approaches to offering mental health 
education to pharmacists (Bell et al., 2006). 
 In recent years, programs have risen to help lower the mental health stigma 
among healthcare professions. A study conducted in 2016 surveyed 32 pharmacists after 
attending a continuing education (CE) program containing consumer-led sessions 
allowing face-to-face interaction with patients with mental illnesses. Although there were 
changes in attitudes and social distancing immediately after the interventions, the results 
were not maintained long-term (Rickles & Dacosta, 2016). Along with other consumer-
led programs, many private organizations have initiated programs to improve mental 
health literacy and decrease mental health stigma. Mental Health First Aid (MHFA), 
established in 2001, developed a set of classes to help develop participants’ abilities to 
“identify, understand and respond” to situations involving those with mental illnesses 
(“About,” 2013).This program is not only available for healthcare professionals but also 
anyone who would like to increase their understanding of mental illness. A 2018 study 
conducted 18 trials with a total of 5,936 participants and concluded that the classes are 
effective in making small changes in the level of stigma, knowledge and recognition up 
to 6-months post-training, but any long-term progress is unclear (Morgan et al., 2018). 
A similar program, More than Meds, hosts courses on improving, specifically 
pharmacists’, level of comfort and understanding of those with mental illness along with 
the face-to-face sessions with patients, similar to that seen in the Rickles study (Murphy, 
2014). Although the program has been developed and used for other purposes, there is a 
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concern with how to determine the effectiveness of the research in relation to pharmacist 
attitudes and how well results are replicated (Murphy et al., 2014). 
 In light of the existing literature related to mental health stigma among pharmacy 
professionals discussed, this study intends to expand upon the literature examining 
mental health stigma in not only health professionals as a whole but specifically 
pharmacists. With a lack of literature documenting the interest of pharmacists in CE 
related to mental illness, this study intends to introduce this to the literature and provide a 
basis for further studies.   
Study Objectives 
In light of the literature available studying pharmacists’ experiences with patients with 
mental illness, the objectives of this study are to: 
1. Measure Mississippi pharmacists’ experience with mental illness. 
2. Measure Mississippi pharmacists’ perceived level of stigma associated with 
mental illness. 
3. Determine if pharmacy experience, mental illness education or mental illness 
work experience is related to pharmacists’ perceived level of stigma associated 
with mental illness. 
4. Measure Mississippi pharmacists’ experiences with, and desire for, continuing 










 The study conducted was an electronic, self-administered, voluntary, anonymous 
survey of pharmacists who were members of the MPhA. It was exempted by the 
University of Mississippi’s Institutional Review Board on December 9, 2019 prior to the 
study being conducted. The study was a descriptive cross-sectional study that was 
conducted at one time with no specific experimental design.  
Sample  
 The study sample included pharmacists who are members of the MPhA. The 
response rate was unable to be obtained due to a transition in leadership immediately 
after release of the survey to pharmacists. 
Data Collection 
 The data was collected using the Qualtrics survey software and was distributed in 
an email giving a brief description of the study objectives and an anonymous link to the 
survey via the MPhA listserv. The email was sent to pharmacists on February 18, 2020, 
and data collection continued for one month. After all data was collected, SPSS v.26 was 
used for any statistical analyses.  
Measures 
 Demographic variables. The demographic characteristics considered in this study 
included age, gender, ethnicity, state of residence and geographic location. 
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Data was also collected regarding the participants’ years of pharmacy experience, 
employment status, the setting of their primary practice and if they have ever worked in a 
setting that specialized in mental health.  
 Experience with Mental Illness. In addition, a question was included to determine 
the participants’ level of general experience with mental illness by providing a range of 
circumstances with different intensities and allowing for all that applied to be marked.  
 Mental Health Stigma. To assess each pharmacist’s level of stigma toward 
patients with mental illnesses, the CAMI Scale was used in its entirety of 40 statements. 
The purpose of utilizing the CAMI scale was to apply a scale that was originally intended 
for a public or community setting to professionals to analyze the general stigma of each 
individual rather than to tailor the scale to solely survey mental health stigma in the 
pharmacy setting. The CAMI scale was used in its original format. The items were scored 
using a 5-point Likert scale with options ranging from “strongly agree” to “strongly 
disagree.” The 40 items were used to assess each participants level of authoritarianism, 
benevolence, social restrictiveness and community mental health ideology and are evenly 
split with 10 items per facet. The authoritarianism subscale focuses on determining 
respondents’ attitudes toward hospitalization of the mentally ill, their differences from 
what is perceived as “normal,” custodial care, and causes of mental illness (Taylor & 
Dear, 2017). The benevolence subscale focuses on respondents’ attitudes toward 
society’s responsibility for the mentally ill, the attitude one should have toward those 
individuals, willingness to be involved with them, and anticustodial feelings (Taylor & 
Dear, 2017). The third subscale titled “social restrictiveness” measures the respondents’ 
stance toward dangerousness of the mentally ill, distancing themselves from them 
 12 
socially, prevention of responsibility, and the normality of those individuals (Taylor & 
Dear, 2017). The fourth and final subscale entitled “community mental health ideology” 
determines attitudes toward the value of community for therapeutic purposes, the effect 
the presence of mental health facilities has on a geographic area, the danger posed to 
residents living in that area, and deinstitutionalized care (Taylor & Dear, 2017). 
 For each subscale analyzed, there were 5 “pro” statements and 5 “anti” statements 
that were dispersed throughout the survey. “Pro” statements are those that indicate a 
positive attitude toward the concepts related to that subscale while “anti” statement 
indicates a negative attitude toward those concepts (Taylor & Dear, 2017).  All 
statements are labeled in Table 4 for each subscale using the appropriate superscript to 
indicate which set they are from. Negative statements were recorded in the dataset before 
analysis. Each subscale also has an overall mean and standard deviation separate from the 
individual items. The overall means are determined by averaging the responses of all 
items and is a number between 10 and 50. In comparison, the mean for each item is found 
by averaging individual responses from participants and is a number between 1 and 5.  
 Social Desirability Bias. Social desirability bias was measured to account for 
CAMI responses that might have been desirable responses as opposed to truthful 
responses, a bias phenomenon that often occurs in social and behavioral research. Social 
desirability bias was assessed using a validated 13-statement revision of the Marlowe-
Crowne Social Desirability Scale (Reynolds, 1982). The scale consists of statements with 
a true-false response format that are to be answered based on if they apply to the 
participant. This revision was used in place of the original in an effort to lower the 
amount of time required to complete the survey and increase the likelihood of a larger 
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number of responses. Each respondents’ social desirability score was calculated by giving 
each statement a value of 0 or 1 dependent on each participants response. By finding the 
value of each statement for all participants, a social desirability score ranging from 0 to 
13 was calculated. A higher social desirability score indicates a higher likelihood that a 
respondent answered in a way that they believed would be culturally favorable or is 




Social Desirability Scale and Response Values 
 True False 
It is sometimes hard for me to go on with my work if I am 
not encouraged. 
0 1 
I sometimes feel resentful when I don't get my way. 0 1 
On a few occasions, I have given up doing something 
because I thought too little of my ability. 
0 1 
There have been times when I felt like rebelling against 
people in authority even though I knew they were right. 
0 1 
No matter who I'm talking to, I am always good listener. 1 0 
There have been occasions when I took advantage of 
someone. 
0 1 
I'm always willing to admit when I make a mistake. 1 0 
I sometimes try to get even rather than forgive and forget. 0 1 
I am always courteous, even to people who are 
disagreeable. 
1 0 
I have never been irked when people expressed ideas very 
different from my own. 
1 0 
There have been times when I was quite jealous of the 
good fortune of others. 
0 1 
I am sometimes irritated by people who ask favors of me. 0 1 





 Continuing Education Interest. The survey concluded with 3 questions pertaining 
to the participants’ amount of continuing education related to mental health along with 
whether there was an interest in the opportunity. There was also a free-response question 
to allow participants to give topics that interested them in relation to mental health and 
those they would like to see in continuing education courses. 
Analysis 
 Frequencies and means were used to present demographic variables. Frequencies 
were calculated to assess objective 1 (measuring pharmacists’ experience with mental 
illness). For objective 2 (measuring pharmacists’ level of stigma associated with mental 
illness), reliability of the CAMI scale was assessed using Cronbach’s alpha. The scale 
mean and per-item means were also calculated. For objective 3 (determining if pharmacy 
experience, mental illness education or mental illness work experience is related to 
pharmacists’ perceived level of stigma associated with mental illness), analysis including 
correlations and independent samples t-tests. Significant differences, if any, were 
detected at p < 0.05. For objective 4 (measuring pharmacists’ experiences with, and 
desire for, continuing education related to mental illness), frequencies were calculated. 
To analyze the qualitative data associated with this research objective, 3 independent 
investigators individually categorized responses into themes. After independently 
identifying themes, the investigators met to come to consensus on themes and resolve any 
disagreement in categorizations. Data was presented in a summated way by presenting 
and discussing example quotes for each theme. 
 In addition, a post-hoc analysis was conducted to determine if years of pharmacy 
experience or previous experience with a mental health specific work setting were related 
 15 
to level of stigma associated with mental illness. An individual analysis for each subscale 
of the CAMI scale was conducted to determine the relationship between each and years 
of experience. To determine if mental illness education or mental illness work experience 
is related to pharmacists’ perceived level of stigma associated with mental illness, 
























 In total, there were 95 respondents that completed at least a portion of the survey. 
22 were missing responses for 25% or more of the stigma scale, resulting in 73 complete 
responses that were able used to be used in the final data analysis. The response rate 
could not be calculated due to a transition in management within the MPhA which 
resulted in the inability to retrieve the total number of pharmacists’ whom received an 
invitation for participation.  
Demographic Characteristics 
 Several demographic questions were included at the beginning of the survey to 
determine the diversity of the respondents for use in the discussion of the data analysis. 
Table 2 below summarizes the raw number value and frequencies of each item for all 
demographic characteristics excluding age and years of practice. For age and years of 
practice, averages were found to be approximately 51 years old and 26 years of practice 
in the pharmacy profession.  
 For the final demographic characteristic determined, labeled “Primary Practice 
Setting” in Table 2, 8 options were given along with an “Other” option to allow 
respondents to describe their primary practice setting if not listed. 9 (12.2%) selected the 
“Other” option and indicated that they would describe their primary practice settings as 




Demographic Data of Survey Respondents 
Characteristics No. Respondents (%) 
Gender 
                    Women 





                    White/Caucasian   
                    Asian/ Asian Indian 
                    African American/Black 
                    Hispanic 
                    American Indian/Alaska Native   








State of Residence 
                    Mississippi                                         
                    Arkansas 
                    Tennessee 
                    Michigan 








                    Urban 
                    Rural 






                     Full-time 
                     Part-time  
                     Unemployed  
Primary Practice Setting 
                     Independent Community Pharmacy  
                     Chain Community Pharmacy                                                         
                     Hospital/Institutional Pharmacy 
                     Other 
                     Long-Term Care 
                     Academia 
    Ambulatory Care 















Objective 1 Results 
 The first objective of this study was to measure the amount of experience the 
sample of pharmacists had with mental illness. Pharmacists were asked to mark all 
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statements that applied to themselves in regard to their personal experience with mental 
illness with each consecutive statement increasing in severity. Table 3 presents the results 
of each statement. Out of all 11 possible responses, the 2 that most of the pharmacists felt 
applied to their personal experience with mental illness were that they had “observed, in 
passing, a person I believe may have had a severe mental illness” and had “watched a 
movie or television show in which a character depicted a person with mental illness.” 
 
TABLE 3 
Mental Illness Familiarity  
 Severity  Frequency  
I have never observed a person that I was aware had a 
severe mental illness. 
1 2 
I have observed, in passing, a person I believe may have 
had a severe mental illness. 
2 55 
I have watched a movie or television show in which a 
character depicted a person with mental illness. 
3 55 
I have watched a documentary on the television about 
severe mental illness.  
4 34 
I have observed persons with a severe mental illness on a 
frequent basis.  
5 25 
My job includes providing services to persons with a 
severe mental illness.  
7 26 
My job involves providing services/treatment for persons 
with a severe mental illness.  
8 35 
A friend of the family has a severe mental illness. 9 23 
I have a relative who has a severe mental illness. 10 28 
I live with a person who has a mental illness. 11 3 
I have a severe mental illness.  12 0 
 
 In addition to the Mental Illness Familiarity survey, a question was included 
following the table to determine the percentage of pharmacists that had experience 
working in a mental health-specific setting. Of the total sample population of 
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pharmacists, 19 (25.7%) indicated that they had, while 55 (74.3%) pharmacists indicated 
they had not.  
 
FIGURE 1 




Objective 2 Results  
 The second objective of this study was to measure the sample of pharmacists’ 
level of stigma associated with mental illness. The data from the CAMI scale collected 
during survey distribution was used through SPSS v.26 to determine the Cronbach’s 
alpha, mean and standard deviation for each of the 4 subscales. The mean and standard 
deviation were also determined for each item.   
 On average, the respondents had low overall scores on the authoritarianism 
subscale, indicating a disagreement with its core concepts. They also scored relatively 
Yes No
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low for the social restrictiveness subscale and therefore disagree with its associated ideas. 
Respondents, on average, agreed with the concepts at the base of the benevolence 
subscale with a large mean score, but averaged in the middle of the scale for the CMHI 
subscale.  
 
TABLE  4 




𝛼 Mean SD   
Authoritarianism subscalea,d 10 0.61 21.56 3.94   
As soon as a person shows signs of mental 
disturbance, he should be hospitalized.b 
  1.96  0.70   
Mental illness is an illness like any other.c   2.07  0.99   
There is something about the mentally ill 
that makes it easy to tell them from normal 
people.b 
  2.11 0.92   
Less emphasis should be placed on 
protecting the public from the mentally ill.c 
  3.01 0.84   
Mental patients need the same kind of 
control and discipline as a young child.b 
  2.58 0.88   
The mentally ill should not be treated as 
outcasts of society.c 
  1.81  1   
The best way to handle the mentally ill is to 
keep them behind locked doors.b 
  1.55 0.67   
Mental hospitals are an outdated means of 
treating the mentally ill.c 
  3.14 0.93   
One of the main causes of mental illness is a 
lack of self-discipline and will power.b 
  1.63 0.72   
Virtually anyone can become mentally ill.c   1.71 0.61   
Benevolence subscalea,d 10 0.69 40.85 4   
More tax money should be spent on the care 
and treatment of the mentally ill.b 
  4.07 0.88   
The mentally ill are a burden on society.c   3.73 0.99   
The mentally ill have for too long been the 
subject of ridicule.b 
  4.30 0.54   
Increased spending on mental health 
services is a waste of tax dollars.c 
  4.20 0.71   
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We need to adopt a far more tolerant 
attitude toward the mentally ill in our 
society.b 
  3.94 0.86   
There are sufficient existing services for the 
mentally ill.c 
  4.14 0.83   
Our mental hospitals seem more like prisons 
than like places where the mentally ill can 
be cared for.b 
  3.42 0.98   
The mentally ill do not deserve our 
sympathy.c 
  4.48 0.65   
We have the responsibility to provide the 
best care for the mentally ill.b 
  4.30 0.64   
It is best to avoid anyone who has mental 
problems.c 
  4.27 0.58   
Social Restrictiveness subscalea,d 10 0.77 23.68 5.02   
The mentally ill should be isolated from the 
rest of the community.b 
  1.82 0.69   
The mentally ill are far less of a danger than 
most people suppose.c 
  2.74 0.91   
A woman would be foolish to marry a man 
who has suffered from mental illness, even 
though he seems fully recovered.b 
  2.25 0.83   
No one has the right to exclude the mentally 
ill from their neighbourhood.c 
  2.34 1.02   
I would not want to live next door to 
someone who has been mentally ill.b 
  2.60 0.92   
Mental patients should be encouraged to 
assume the responsibilities of normal life.c 
  2.22 0.77   
Anyone with a history of mental problems 
should be excluded from taking public 
office.b 
  2.44 0.94   
The mentally ill should not be denied their 
individual rights.c 
  2.15 1.21   
The mentally ill should not be given any 
responsibility.b 
  1.88 0.50   
Most women who were once patients in a 
mental hospital can be trusted as baby 
sitters.c 
  3.26 0.83   
Community Mental Health Ideology 
subscalea,d 
10 0.89 34.78 6.10   
The best therapy for many mental patients is 
to be part of a normal community.b 
  3.78 0.71   
Locating mental health facilities in a 
residential area downgrades the 
neighborhood.c 
  3.37 1   
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As far as possible mental health services 
should be provided through community-
based facilities.b 
  4.01 0.66   
Having mental patients living within 
residential neighborhoods might be good 
therapy, but the risks to residents are too 
great.c 
  3.52 0.85   
Residents should accept the location of 
mental health facilities in their 
neighbourhood to serve the needs of the 
local community.b 
  3.25 0.89   
Local residents have good reason to resist 
the location of mental health services in 
their neighbourhood.c 
  3.40 0.94   
Locating mental health services in 
residential neighbourhoods does not 
endanger local residents.b 
  3.30 0.86   
Mental health facilities should be kept out of 
residential neighbourhoods.c 
  3.30 0.83   
Residents have nothing to fear from people 
coming into their neighborhood to obtain 
mental health services.b 
  3.22 0.95   
It is frightening to think of people with 
mental problems living in residential 
neighborhoods.c 
  3.64 0.81   
a Measured on a 5-point scale where 5 = Strongly Agree and 1 = Strongly Disagree 
b “Pro” statements 
c “Anti” statements – these statements were recoded before analysis 
d Overall means are out of 50. 
 
Objective 3 Results 
 The third objective of this study was to determine if pharmacy experience, mental 
illness education or mental illness work experience is related to pharmacists’ perceived 
level of stigma associated with mental illness.  
 Years in practice was significantly and positively correlated with 
Authoritarianism (r = 0.358; p = .003) and Social Restrictiveness (r = 0.446; p = .000) 
and was significantly and negative correlated with Benevolence (r = -0.250; p = .039) and 
Community Mental Health Ideology (r = -0.330; p = 006).  
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 When comparing pharmacists that had taken no continuing education in mental 
illness versus those that have, there were no differences in CAMI scores for any of the 4 
domains. When comparing pharmacists that had work experience in a setting that 
specialized in mental illness to pharmacists that did have experience in a setting 
specializing in mental illness, there were again, no difference in CAMI scores for any of 
the 4 domains.  
Objective 4 Results 
 The fourth and final objective of this study was to determine the desire and need 
for continuing education related to mental health or mental illnesses along with what 
specifically pharmacists desired to be educated on. The first question of this three-
question series was if the respondents had ever taken any continuing education related to 
mental health previously. The results of this question can be found in Figure 2, in which 
42 (56.8%) reported that they had while 32 (43.2%) reported that they had not.  
 
FIGURE 2 




 The second question assessed whether there was an interest in continuing 
education focused on mental health. Presented in Figure 3, 63 (85.1%) pharmacists 
reported that they were interested while 11 (14.9%) were not interested.  
 
FIGURE 3 






 The third and final question of the series gave the pharmacists who reported that 
they were interested in mental health continuing education an opportunity to present 
topics they would like discussed. Among the responses, there were a few categories that 
many respondents shared interest in. Firstly, many pharmacists were interested in 
education on specific conditions such as substance abuse, addiction, attention deficit 
disorder (ADD), bipolar disorder, depression, anxiety, obsessive-compulsive disorder 
(OCD), dementia, post-traumatic stress disorder (PTSD) and schizophrenia. Other 
pharmacists indicated interest in being educated on topics related to the broader spectrum 
of mental illnesses such as the specific types that exist, updates on medications for mental 
health as a whole, causes of mental illness and treatments that are available. A third 
category that emerged is an interest in continuing education focused on more specific 
topics related to mental health such as the mental health of new mothers with post-partum 
depression, the use of antipsychotics for patients with dementia and ketamine for 
depression, teenage mental health, medication compliance specifically in mental health 
patients, dispensing medication to those with substance abuse or alcoholism, and mental 
health-related concerns in those with dementia or Alzheimer’s living in long-term care 
facilities. The final category that many pharmacists were interested in was the general 
treatment of those living with mental illnesses. This category included an interest in what 
it is like living with a mental illness, how to properly approach a situation involving 
psychotic patients, understanding the needs of mental health patients and how best to 
assist them, treatment of those living with co-morbid mental illnesses, denial of benefits 
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that is associated with such disorders, the effect of counseling, and ultimately how to 


























 For the authoritarianism subscale, the “pro” statements had an encouragingly low 
mean of 1.97, and the “anti” statements also had a low mean of 2.3 (where 1 = strongly 
disagree and 5 = strongly agree). Although it seems that respondents displayed a strong 
agreement with viewing mental health patients as normal people in comparison to those 
with other illnesses, other statements suggested that respondents did not fully agree that 
mental health patients were “normal.” The statement stating the need for control and 
discipline had a mean of 2.58, indicating that responses averaged close to neutral rather 
than disagreeing. In addition, the statement that patients should not be treated as outcasts 
received a surprising low mean of 1.81, seeming to indicate agreement with viewing 
mental health patients as outsiders. Respondents did express disagreement with 
hospitalization and the view that mental illness can be caused by controllable 
circumstances. 
 With the benevolence subscale having a mean of 40.85 out of possible total score 
of 50, respondents overall agreed with the concepts that influenced the statements of the 
subscale. The “anti” statements had a high mean of 4.16, but the “pro” statements also 
had a high mean of 4.00, indicating that their responses were not as polarized as they 
seemed. The statements indicating the beliefs that tax dollars are wasted on mental health 
services, that mental health patients deserve no sympathy, and that they should be 
avoided received surprisingly high means of 4.2, 4.48, and 4.27. Agreement with these 
signifies the presence of mental health stigma in their views of how one’s attitude should 
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be toward those with mental illness and societies involvement with them. Additionally, 
they did agree that more tax money should be spent on treatment and that we have the 
responsibility to provide care which could indicate some indecisiveness about the 
responsibilities of society. 
 Respondents, based on the overall average, disagreed with the fundamental 
concepts underlying the third subscale of social restrictiveness including levels of danger 
patients impose, need for social distancing, preventing responsibility from being placed 
with patients, and the normality of patients. Based on the individual means for each item, 
the sample group seemed to express positive attitudes toward patients with mental illness 
in relation to social restrictiveness subscale with no strong indication of mental health 
stigma related to it. There were 2 statements, though, had surprising responses. With a 
mean of 2.22, respondents mostly disagreed with encouraging mental health patients to 
assume the responsibilities of normal life. They also mostly disagreed that they should 
not be denied their rights, indicating that there is a low level of stigma potentially present.  
 For the community mental health ideology subscale, the overall mean averaged 
toward the middle of spectrum with the largest standard deviation of all the subscales at 
6.10. In comparison between the “pro” and “anti” statements, respondents averaged 
similar responses for both. Some statements that received higher averages than expected 
were those stating that locating mental health facilities downgrade the area, having these 
facilities poses a risk to residents and that resisting the placement of these facilities in 
neighborhoods is in good reason. Based on the results of all subscales presented, it could 
be said that the sample group of pharmacists did not display a strong presence of mental 
health stigma. 
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 The Marlowe-Crowe Social Desirability Scale, as presented in Table 1, has a 
score range of 1 to 13. The mean score of all respondents was found to be 7.65, indicating 
that it is likely that their responses to the CAMI scale portion of the survey may not have 
been highly influenced by a concern with social acceptance.  
 Studies also using the CAMI scale can be found determining stigma levels of 
health professionals other than pharmacists. A study of 64 respondents found that mental 
health professionals, including the Department of Youth Services staff, reported 
disagreeing more strongly with the authoritarianism and social restrictiveness subscales 
with means of 19.6 and 17.3 compared to the means of 21.56 and 23.68 found for 
pharmacists in this study. They also reported agreeing more strongly with the 
benevolence and CMHI subscales with means of 42.8 and 38.8 compared to the means of 
40.85 and 34.78 found for pharmacists (Browne, 2010). This comparison could indicate a 
larger presence of stigma in pharmacists when compared to mental health professionals. 
Another study examining the mental health stigma of nursing students with a sample 
group of 90 indicates that the nurses scored similarly to the pharmacists in this study for 
the social restrictiveness and CMHI subscales with means of 23.60 and 34.94, but agreed 
more with the authoritarianism subscale (M=23.27) and less with benevolence subscale 
(M=38.49) (Morrison, 2011). This could suggest a higher presence of stigma found in 
nurses compared to pharmacists. 
 A surprising result from the demographic portion of the survey was the lack of 
respondents indicating that they had a mental illness. With statistics from 2018 finding 
that not only did one in every 25 have a serious mental illness, but that 1 in every 5 had 
any mental illness, it came as a surprise that no respondents reported having a mental 
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illness (“Mental Illness,” 2019). Another surprising result, from the continuing education 
portion of the survey, was that more pharmacists had previously taken a continuing 
education course related to mental health than had not. Although this was originally 
unexpected, this could potentially have been related to the lower level of stigma found 
when interpreting the CAMI scale results. An interesting result additionally came from 
the final question allowing pharmacists to report what they would be interested in being 
educated on while taking a CE course focused on mental health. The expectation when 
including that addition to the survey was that a few respondents would choose to respond 
but there was actually a large response rate reporting a wide range of interests. It would 
be interesting to see the impact implementing these results would have on attendance and 
impact of CE courses focused on mental health.  
 For the question used to determine respondents’ level of personal experience with 
mental illness, multiple of the frequencies could be explained or expected. Considering 
the statistic presented previously about the frequency of mental illness in the United 
States, it is not surprising that only 2 pharmacists out of the 74 respondents reported 
having never encountered someone with a mental illness. Although it seems that it would 
be difficult to say that one has never encountered someone at all with a mental illness, 
this result could suggest that mental illness is not as obvious as previously perceived. The 
frequency of those who reported having seen someone in passing or on a television show 
or movie was much higher than those of the other statements, supporting the idea 
previously mentioned that media plays a large role in defining mental illness for the 
majority of Americans today. Another result that could be anticipated was that 
approximately half of the respondents reporting that they provide treatment and services 
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for those with mental illness. This could be referencing many different aspects of the 
everyday workflow of pharmacists nationally including distributing and counseling 
patients on their medications, medication adherence programs and even additional 
services in more specialized settings. The final result of objective to consider is the 
indication that the majority of respondents worked in a retail setting but not many of the 
have worked in a mental-health specific setting. With the majority of pharmacies in the 
United States being chain and independent retail pharmacies, the career opportunities are 
much more accessible compared to pharmacies in a mental-health specific setting.  
 Some results of the CAMI scale portion of the survey came at a surprise while 
others could have been expected. First, based on the responses for multiple questions 
regarding how “normal” those with mental illnesses are, one could say that the 
respondents were conflicted on their views about this. With defining “normal” being 
strongly influenced by subjective and societal perceptions, each person defines the term 
“normal” differently with that definition being quite dynamic and ever-changing which 
could explain the confliction in regard to these statements. Additionally, the results 
indicated that the majority of pharmacists believed that patients with mental illnesses 
should be viewed as outcasts that do not deserve sympathy. Further research may be 
needed to clarify this finding. The statements regarding hospitalization and the cause of 
mental illness being controllable, in contrast, had polarizing results toward disagreement. 
This result may have been a function of their medical education that contributed to their 
levels of empathy toward patients with mental illness. Another set of statements whose 
results should be considered were those focused around the distribution of tax dollars and 
their role in aiding those with mental illnesses. Responses suggested that pharmacists 
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were also conflicted about this topic. As previously mentioned, mental illness is costly to 
employers and has a large impact on the economy which could have influenced their 
responses to those statements. It could also be related to the current political climate with 
the distribution of tax dollars being a sensitive topic for the upcoming presidential 
election. Also, there was slight indication that patients with mental illness should be 
restricted in their levels of responsibilities and rights. This could have also been due to 
the media influence on how those with mental illnesses are viewed, which is mostly an 
exaggerated and inaccurate picture of the reality of mental illness. Finally, the 
respondents were conflicted about whether mental health facilities should be allowed in 
residential areas. The media showing those with mental illnesses as violent or unstable 
could have contributed to this and caused respondents to consider the safety of the 
residents of the neighborhoods.  
When comparing CAMI scores among pharmacists with differing years of 
experience, mental illness education, and mental illness work experience, the amount of 
continuing education they completed with regard to mental illness or the amount of 
experience that had working at a mental illness facility did not seem to impact CAMI 
scores. Our evaluation of pharmacist’s continuing education or work experience with 
regard to illness were very basic “yes-no” questions, so further evaluation may be needed 
to draw conclusions over the possible impact of continuing education and work 
experience. However, when correlating overall years of total work experience with 
CAMI scores, it was found that more years of work experience as a pharmacist 
significantly and positively related to Authoritarianism and Social Restrictiveness and 
negatively and significantly related to Benevolence and Community Mental Health 
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Ideology. While this finding needs more exploration, it may lead to the question as to 
whether pharmacists develop more negative perceptions of the mentally ill the longer 
they are in practice. 
 For objective 4, determining the need and desire for continuing education, many 
responses resulted in both expected and unexpected results. When originally considering 
the need for continuing education specific to mental illness, it was projected that more 
respondents than not had not taken a similar course. The findings, however, show that 
more pharmacists had actually taken a course like this at some point in their pharmacy 
practice. This may be related to the lower levels of stigma revealed from the CAMI scale 
results. The majority of pharmacists, although most had taken a course previously, 
surprisingly expressed interest in mental health-specific continuing education. With 
multiple pharmacists indicating interest in understanding how to handle situations 
involving mental health patients and how to best assist them, the respondents’ lack of 
comfort may have been an influence in this result. Education on specific disorders was 
another topic that reappeared repeatedly in the results of objective 4 and proposed a 
surprising interest in not mental health in general but understanding each individual 
disorder. This interest could also be influenced by the respondents’ lack of comfort and 
search for understanding not only the social aspect but the biological aspects of mental 
health as well. Although the sample group of pharmacists were not surveyed on their 
opinion in the quality of mental health education they received during their college 
career, the request for broader spectrum topics that focus on basic knowledge about 
mental illness could be an indication of their confidence in the knowledge. This result 
was observed in similar studies and was not a completely unexpected results (CITE).  
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 Based on the results of the CAMI scale analysis, it can be said that the sample 
group did not express a high level of mental health stigma but did report not feeling 
confident in their knowledge of a variety of topics. Similar results were presented in a 
study in which pharmacists showed interest in offering mental health patients counseling 
and additional services to aid in improving their quality of treatment but felt that they 
lacked the knowledge and confidence to do so (Giannetti et al., 2018). As a respondent in 
Watkins’ study said, “the health care profession needs sensitivity training that recognizes 
mental health issues as a disease just as acceptable as diabetes, hypertension and other 
common disease” (Watkins et al., 2017). This could potentially increase the level of 
comfort pharmacists have with personal interactions with mental health patients by 
making them aware of the way their personal beliefs effect their behaviors in such 
situations.  It could also improve the patients’ outlook on themselves and their condition 
(Knaak et al., 2017).   
 To begin the discussion of the steps needed to offer these courses, a few concerns 
must be taken into consideration. First, the cost of continuing education could play a 
large role in promoting an incentive to take these continuing education courses. With 
many employees incurring out of pocket costs for their CE courses, the cost may be 
playing a larger role in their choices than the content. According to the Publication 535 of 
the IRS, employers have the opportunity to write off any expense concurred to reimburse 
employees for their CE on their taxes as a portion of their business expenses. Previously, 
out-of-pocket costs could be written off on the employees’ personal taxes as work-related 
expenses with the addition of a Schedule A form to include itemized deductions if their 
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employer decided against reimbursement, but as of 2017 W-2 employees are no longer 
able to do so (United States). Grants to cover the expenses of such classes could be 
another avenue for offering a course to a larger group of pharmacists. Non-profit 
organizations such the Community Pharmacy Foundation have funded grants in the past 
for courses such as the Mental Health First Aid program but currently do not offer grants 
specifically to fund continuing education unless part of a larger grant project. Another 
obstacle to encouraging the attendance of mental health CE courses is encouraging 
attendance when other options are available. According to the Mississippi Board of 
Pharmacy, pharmacists are required to complete 15 hours of CE for 2020, with 5 hours 
dedicated to opioid abuse and at least 2 to a live seminar. (“Continuing Education 
Requirements,” 2018). Finding a way for courses such as MHFA to count toward those 
hours could provide incentive. Another option for increasing the likelihood of 
pharmacists being interested is potentially offering courses online that allow pharmacists 
to fit such an intensive course into their already busy schedules.  
 The most important discussion to be had in regard to this study is its application 
to society, specifically the impact it could have to better pharmacists’ understanding and 
level of comfort with mental illness and how this will improve the quality of treatment 
mental health patients receive universally. With pharmacists mostly reporting a lack of 
comfort in not only this study but also previous studies, mental health CE could offer the 
training needed to help fill the gaps of knowledge and understanding needed for 
participants to feel more comfortable. As Dr. Nathanial Rickles, a professor of pharmacy 
practice explained, gaps could include a lack of training on how to screen patients, how 
to offer supportive interventions and the education needed to be able to offer referrals for 
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additional treatment, which are not typical of pharmacy curriculums (Rickles, 2018). This 
could present the opportunity to offer additional services such as the implementation of 
multidisciplinary health care teams and depression screenings. Although pharmacies 
offering depression screenings is still currently being researched and tested, such a 
service could offer a simple and cost-effective way to decrease the amount of mental 
health patients living without the treatment they need and decrease the difference of the 
number of services available in comparison to those with chronic illnesses such as 
diabetes and hypertension (Rubio-Valera et al., 2014).   
Limitations 
 When considering the results of this study, some limitations arose that could 
affect the application of this project to larger sample populations. With approximately 91 
percent of the sample group identifying as Caucasian and 85 percent practicing in 
Mississippi, the lack of ethnic and geographical diversity limits the applications of this 
study to a larger population. Additionally, the small sample size could also affect the 
survey results’ ability to be applicable to a larger population size. The final important 
limitation to the study is the possibility of differences in perception of what “mental 
illness” is. Although a definition was given in the instructions of the CAMI scale, 
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